PsiOxus Therapeutics Limited
Registration country:United Kingdom
A biotechnology company using non-traditional approaches to develop novel therapeutics.
PsiOxus Therapeutics is using non-traditional approaches to develop novel therapeutics that address cancer and other clinically unmet diseases. The Company is also developing treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines.